Patents by Inventor Lloyd Wolfinbarger, Jr.
Lloyd Wolfinbarger, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6916910Abstract: The present invention relates to a process for the production of marine invertebrate type V telopeptide containing collagen preparations from marine invertebrates, compositions containing preparations, and methods of using these preparations. The collagen preparation includes telopeptide containing and optionally invertebrate atelopeptide containing, type V fibrillar collagen. The present collagen preparations may be employed in a variety of products including for example, cosmetic, pharmacological, dental, and cell culture products.Type: GrantFiled: November 28, 2001Date of Patent: July 12, 2005Assignee: Bioscience ConsultantsInventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 6902578Abstract: The invention is directed to a composite bone graft for implantation in a patient, and methods of making and using the composite bone graft, along with methods for treating patients by implanting the composite bone graft at a site in a patient. The composite bone graft includes two or more connected, discrete, bone portions, and includes one or more biocompatible connectors which hold together the discrete bone portions to form the composite bone graft. The composite bone graft may include one or more textured bone surfaces. The textured surface preferably includes a plurality of closely spaced protrusions, preferably closely spaced continuous protrusions. The composite bone graft is useful for repairing bone defects caused by congenital anomaly, disease, or trauma, in a patient, for example, for restoring vertical support of the anterior and/or posterior column. Implantation of the composite bone graft results in improved graft stability and osteoinductivity, without a decrease in mechanical strength.Type: GrantFiled: October 27, 2000Date of Patent: June 7, 2005Assignee: LifeNetInventors: Billy G. Anderson, Lloyd Wolfinbarger, Jr.
-
Patent number: 6837907Abstract: The invention is directed to a method of debriding bone including incubating the bone and associated soft tissue, with one or more debriding solutions where the debriding solution may include one or more alkaline solutions. Incubation is optionally carried out with one or more debriding agents including inert dry granular or particulate material including for example beads, and the granular phase of an alkaline agent, including for example granular sodium hydroxide. The incubating may be carried out with agitation. In another embodiment, the medullary canal of the bone is subjected to a positive pressure stream of debriding solution under conditions sufficient to loosen the associated soft tissue from the bone at the interface of the soft tissue and bone. In a further embodiment, the debriding solution is provided as a gel.Type: GrantFiled: March 27, 2002Date of Patent: January 4, 2005Assignee: LifeNetInventors: Lloyd Wolfinbarger, Jr., Robert K. O'Leary, Louis Ford, Alyce Linhurst Jones
-
Patent number: 6830763Abstract: The invention is directed to a process for producing demineralized osteoinductive bone, and demineralized osteoinductive bone produced thereby. The process achieves demineralization of bone by subjecting bone, including for example ground bone, bone cubes, chips, strips, or essentially intact bone, to a rapid continuous acid demineralization process. The process includes subjecting bone to a continuous exchange of demineralizing acid solution where the demineralizing acid solution is recirculated from the substantially closed container through an ion exchange media to remove calcium and phosphate thereby producing a regenerated acid, and returning the regenerated acid to the substantially closed container to produce osteoinductive demineralized bone. The process allows bone to be rapidly demineralized to a precise and specific desired residual calcium level, without sacrificing osteoinductivity.Type: GrantFiled: June 26, 2002Date of Patent: December 14, 2004Assignee: LifeNetInventors: Robert K. O'Leary, Jan Zajdowicz, Lloyd Wolfinbarger, Jr.
-
Patent number: 6743574Abstract: The invention provides methodologies and apparatus for producing devitalized soft-tissue implants where the implant retains metabolically non-viable and/or reproductively non-viable cells, and preferably retains large molecular weight cytoplasmic proteins, such implants produced both in small quantities and in commercializable quantities. Such soft-tissue implants include vascular graft substitutes. An devitalized graft is produced by subjecting the tissue sample to an induced pressure mediated flow of an extracting solution, optionally followed by inducing a pressure mediated flow of a salt solution, then washing the tissue to produce the devitalized graft. The devitalized grafts produced are uniform and non-immunogenic. The inventive method allows for the production of multiple devitalized soft tissue implants, where processing time is significantly less than prior art processes and the number of implants produced per day is increased over prior art processes.Type: GrantFiled: September 12, 2000Date of Patent: June 1, 2004Assignee: LifenetInventors: Lloyd Wolfinbarger, Jr., Perry Lange, Alyce Linhurst, Eric Moore, Barry Nolf
-
Patent number: 6734018Abstract: The invention provides methodologies and apparatus for producing acellular soft-tissue implants, both in small quantities and in commercializable quantities. Such soft-tissue implants include vascular graft substitutes. An acellular graft is produced by subjecting the tissue sample to an induced pressure mediated flow of an extracting solution, followed by inducing a pressure mediated flow of a treating solution, then washing the treated tissue to produce the acellular graft. The acellular grafts produced are uniform and non-immunogenic. The inventive method allows for the production of multiple decellularized soft tissue implants, where processing time is significantly less than prior art processes and the number of implants produced per day is increased over prior art processes. In clinical use, the decellularized grafts produced exhibit significantly improved in long-term durability and function.Type: GrantFiled: March 17, 2000Date of Patent: May 11, 2004Assignee: LifenetInventors: Lloyd Wolfinbarger, Jr., Perry Lange, Alyce Linhurst, Eric Moore, Barry Nolf
-
Patent number: 6569200Abstract: The present invention provides a plasticized dehydrated or freeze-dried bone and/or soft tissue product that does not require special conditions of storage, for example refrigeration or freezing, exhibits materials properties that approximate those properties present in normal hydrated tissue, is not brittle, does not necessitate rehydration prior to clinical implantation and is not a potential source for disease transmission. The invention replaces water in the molecular structure of the bone or soft tissue matrix with one or more plasticizers allowing for dehydration of the tissue, yet not resulting in an increase in brittleness of the plasticized product, and resulting in compressive and/or tensile properties similar to those of normal hydrated bone. Replacement of the chemical plasticizers by water prior to implantation is not required and thus, the dehydrated bone or soft tissue plasticized product can be placed directly into an implant site without significant preparation in the operating room.Type: GrantFiled: June 5, 2001Date of Patent: May 27, 2003Assignee: LifeNetInventors: Lloyd Wolfinbarger, Jr., Robert K. O'Leary, Billy G. Anderson
-
Patent number: 6544289Abstract: The present invention provides a plasticized dehydrated or freeze-dried bone and/or soft tissue product that does not require special conditions of storage, for example refrigeration or freezing, exhibits materials properties that approximate those properties present in normal hydrated tissue, is not brittle, does not necessitate rehydration prior to clinical implantation and is not a potential source for disease transmission. The invention replaces water in the molecular structure of the bone or soft tissue matrix with one or more plasticizers allowing for dehydration of the tissue, yet not resulting in an increase in brittleness of the plasticized product, and resulting in compressive and/or tensile properties similar to those of normal hydrated bone. Replacement of the chemical plasticizers by water prior to implantation is not required and thus, the dehydrated bone or soft tissue plasticized product can be placed directly into an implant site without significant preparation in the operating room.Type: GrantFiled: June 22, 2001Date of Patent: April 8, 2003Assignee: LifeNetInventors: Lloyd Wolfinbarger, Jr., Robert K. O'Leary, Billy G. Anderson
-
Patent number: 6511509Abstract: The present invention is directed to a textured bone allograft for implantation in a patient, having one or more textured bone surfaces, and methods of making and using the textured bone graft. The textured surface preferably includes a plurality of closely spaced discrete, continuous, or a combination thereof, protrusions. The textured bone allograft is useful for repairing bone defects caused by congenital anomaly, disease, or trauma, in a patient, for example, for restoring vertical support of the anterior column. Implantation of the textured bone allograft results in improved graft stability and osteoinductivity, without a decrease in mechanical strength. The textured bone allograft does not shift, extrude or rotate, after implantation.Type: GrantFiled: May 7, 1998Date of Patent: January 28, 2003Assignee: LifeNetInventors: Louis Ford, Lloyd Wolfinbarger, Jr., Jon C. Serbousek, Laine Mashburn, Jr.
-
Patent number: 6458158Abstract: The invention is directed to a composite bone graft for implantation in a patient, and methods of making and using the composite bone graft, along with methods for treating patients by implanting the composite bone graft at a site in a patient. The composite bone graft includes two or more connected, discrete, bone portions, and includes one or more biocompatible connectors which hold together the discrete bone portions to form the composite bone graft. The composite bone graft may include one or more textured bone surfaces. The textured surface preferably includes a plurality of closely spaced protrusions, preferably closely spaced continuous protrusions. The composite bone graft is useful for repairing bone defects caused by congenital anomaly, disease, or trauma, in a patient, for example, for restoring vertical support of the anterior and/or posterior column. Implantation of the composite bone graft results in improved graft stability and osteoinductivity, without a decrease in mechanical strength.Type: GrantFiled: October 27, 2000Date of Patent: October 1, 2002Assignee: LifeNetInventors: Billy G. Anderson, Lloyd Wolfinbarger, Jr.
-
Patent number: 6432712Abstract: The invention provides a device and process for recellularizing essentially acellular or devitalized tissue grafts, including for example essentially acellular or devitalized vascular tissue grafts, derived from human or animal sources, or as constructed using any number of tissue engineering methodologies. The process includes repopulating and reendothelializing an essentially acellular or devitalized tissue graft. The device is useful for producing a repopulated tissue graft from an essentially acellular or devitalized tissue, as well as for producing an essentially acellular or devitalized tissue graft.Type: GrantFiled: June 16, 2000Date of Patent: August 13, 2002Assignee: Bioscience Consultants, LLCInventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 6337389Abstract: The present invention relates to a process for the production of marine invertebrate type V telopeptide containing collagen preparations from marine invertebrates, compositions containing preparations, and methods of using these preparations. The collagen preparation includes telopeptide containing and optionally invertebrate atelopeptide containing, type V fibrillar collagen. The present collagen preparations may be employed in a variety of products including for example, cosmetic, pharmacological, dental, and cell culture products.Type: GrantFiled: October 28, 1997Date of Patent: January 8, 2002Assignee: BioScience Consultants, L.L.C.Inventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 6326188Abstract: The present invention is directed to a continuous, multi-step dilution process for producing tissue suitable for transplantation into a human from cryopreserved tissue. Cryopreserved tissue is subjected to a continuous flow of wash-out solution following a thawing or simultaneously thawing using the present continuous perfusion chamber. The present continuous perfusion chamber may be rigid or deformable and has an inlet port and an outlet port.Type: GrantFiled: October 13, 1998Date of Patent: December 4, 2001Assignee: LifeNetInventors: Lloyd Wolfinbarger, Jr., Perry Lange
-
Patent number: 6305379Abstract: A process is disclosed for producing osteoinductive bone using a controlled-flow apparatus. The present apparatus allows for the controlled extraction of undesirable constituents from a body tissue. The present invention provides for the demineralization of ground bone particles or pieces of cancellous or cortical bone which permits the controlled and reproducible demineralization of bone to produce bone which is maximally osteoinductive. It has been demonstrated that ground cadaveric bone which is demineralized to a residual calcium level approximating 2% by dry weight of bone is optimally osteoinductive as assayed using in vivo and in vitro assays of osteoinductivity. The present controlled-flow apparatus includes one or more solution containers which supply solutions to be pumped into one or more vessels filled with tissue samples to be extracted. Solvent outflowing from the vessels can be monitored for pH, calcium ion concentration or conductivity as a basis for determining when extraction is complete.Type: GrantFiled: April 12, 2000Date of Patent: October 23, 2001Assignee: LifeNetInventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 6293970Abstract: The present invention provides a plasticized dehydrated or freeze-dried bone and/or soft tissue product that does not require special conditions of storage, for example refrigeration or freezing, exhibits materials properties that approximate those properties present in normal hydrated tissue, is not brittle, does not necessitate rehydration prior to clinical implantation and is not a potential source for disease transmission. The invention replaces water in the molecular structure of the bone or soft tissue matrix with one or more plasticizers allowing for dehydration of the tissue, yet not resulting in an increase in brittleness of the plasticized product, and resulting in compressive and/or tensile properties similar to those of normal hydrated bone. Replacement of the chemical plasticizers by water prior to implantation is not required and thus, the dehydrated bone or soft tissue plasticized product can be placed directly into an implant site without significant preparation in the operating room.Type: GrantFiled: June 30, 1998Date of Patent: September 25, 2001Assignee: LifeNetInventors: Lloyd Wolfinbarger, Jr., Robert K. O'Leary, Billy G. Anderson
-
Patent number: 6200347Abstract: The invention is directed to a composite bone graft for implantation in a patient, and methods of making and using the composite bone graft, along with methods for treating patients by implanting the composite bone graft at a site in a patient. The composite bone graft includes two or more connected, discrete, bone portions, and includes one or more biocompatible connectors which hold together the discrete bone portions to form the composite bone graft. The composite bone graft may include one or more textured bone surfaces. The textured surface preferably includes a plurality of closely spaced protrusions, preferably closely spaced continuous protrusions. The composite bone graft is useful for repairing bone defects caused by congenital anomaly, disease, or trauma, in a patient, for example, for restoring vertical support of the anterior and/or posterior column. Implantation of the composite bone graft results in improved graft stability and osteoinductivity, without a decrease in mechanical strength.Type: GrantFiled: August 3, 1999Date of Patent: March 13, 2001Assignee: LifeNetInventors: Billy G. Anderson, Lloyd Wolfinbarger, Jr.
-
Patent number: 6189537Abstract: The invention produces osteoinductive bone using a controlled-flow apparatus. The apparatus allows for the controlled extraction of undesirable constituents from a body tissue. The invention provides for the demineralization of ground bone particles or pieces of cancellous or cortical bone which permits the controlled and reproducible demineralization of bone to produce bone which is maximally osteoinductive. It has been demonstrated that ground cadaveric bone which is demineralized to a residual calcium level approximating 2% by dry weight of bone is optimally osteoinductive as assayed using in vivo and in vitro assays of osteoinductivity. The controlled-flow apparatus includes one or more solution containers which supply solutions to be pumped into one or more vessels filled with tissue samples to be extracted. Solvent outflowing from the vessels can be monitored for pH, calcium ion concentration or conductivity as a basis for determining when extraction is complete.Type: GrantFiled: September 6, 1996Date of Patent: February 20, 2001Assignee: LifeNetInventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 6024735Abstract: The invention relates to compositions effective for the cleansing of mammalian soft tissue optionally attached to bones, and particularly the removal of blood deposits and bone marrow therefrom. The compsotions are composed of an aqueous solution containing as its essential ingredients a detergent having a functionality of the nature of a polyoxyethylene-23-lauryl either, a detergent having a functionality of the nature of exyethylated alkylphenol, and water, where the compositions are free from any membrane stabilizers. The present invention is also directed to a method and composition for cleaning cadaveric soft tissue optionally attached to bone to produce soft tissue grafts optionally attached to bone suitable for transplantation into a human. The present method involves removing bone marrow elements, blood deposits and any bacteria, virus or fungi contamination, from the donor bone and/or associated soft tissues.Type: GrantFiled: July 16, 1997Date of Patent: February 15, 2000Assignee: LifeNet Research FoundationInventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 5977034Abstract: The invention relates to compositions effective for the cleansing of mammalian bones and particularly the removal of bone marrow and like blood deposits therefrom. The compositions are composed of an aqueous solution containing as its essential ingredients a detergent having a functionality of the nature of a polyoxyethylene-23-lauryl ether, a detergent having a functionality of the nature of oxyethylated alkylphenol, and water, where the compositions are free from any membrane stabilizers. The detergent having a functionality of the nature of a lauryl ether and the detergent having a functionality of the nature of oxyethylated alkylphenol are present in a weight percent ratio of about 1.65:1.Type: GrantFiled: March 20, 1996Date of Patent: November 2, 1999Assignee: LifeNet Research FoundationInventor: Lloyd Wolfinbarger, Jr.
-
Patent number: 5977432Abstract: A process for removing essentially all bone marrow from a cut bone graft and the cut bone graft produced thereby. A large substantially intact bone is selected and excess cartilage and associated soft tissues are removed from the surface of the bone. The bone is left whole or may be cut into appropriate smaller pieces constituting cut grafts and bone marrow is removed from the cancellous bone spaces of the small cut grafts through the application of centrifugal force. Prior to and/or following the application of centrifugal force, the bone graft may optionally be pretreated with one or more decontaminating agents, and/or solubilizing agents.Type: GrantFiled: June 9, 1997Date of Patent: November 2, 1999Assignee: Life Net Research FoundationInventors: Lloyd Wolfinbarger, Jr., Louis Ford